X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24) 24
index medicus (18) 18
aged (17) 17
female (17) 17
male (17) 17
oncology (15) 15
cancer (14) 14
lung cancer, non-small cell (14) 14
middle aged (14) 14
chemotherapy (13) 13
lung cancer (13) 13
carcinoma, non-small-cell lung - drug therapy (12) 12
lung neoplasms - drug therapy (12) 12
lung neoplasms - pathology (12) 12
mutation (11) 11
care and treatment (10) 10
research (10) 10
adult (9) 9
lung neoplasms - genetics (9) 9
aged, 80 and over (8) 8
cancer therapies (8) 8
carcinoma, non-small-cell lung - genetics (8) 8
gefitinib (7) 7
metastasis (7) 7
patients (7) 7
carcinoma, non-small-cell lung - pathology (6) 6
epidermal growth factor (6) 6
tumors (6) 6
abridged index medicus (5) 5
antibodies, monoclonal - administration & dosage (5) 5
antineoplastic agents - therapeutic use (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
carboplatin (5) 5
carcinoma, non-small-cell lung - metabolism (5) 5
egfr (5) 5
immunotherapy (5) 5
lung neoplasms - metabolism (5) 5
medical prognosis (5) 5
non-small cell lung cancer (5) 5
non-small cell lung carcinoma (5) 5
risk factors (5) 5
survival (5) 5
survival rate (5) 5
therapy (5) 5
adenocarcinoma (4) 4
analysis (4) 4
apoptosis (4) 4
carcinoma, non-small-cell lung - mortality (4) 4
clinical trials (4) 4
docetaxel (4) 4
drug therapy (4) 4
erlotinib (4) 4
gene mutations (4) 4
genetic aspects (4) 4
health aspects (4) 4
immunohistochemistry (4) 4
lung neoplasms - mortality (4) 4
metastases (4) 4
neoplasm staging (4) 4
paclitaxel (4) 4
phase-ii trial (4) 4
protein kinase inhibitors - therapeutic use (4) 4
receptor, epidermal growth factor - genetics (4) 4
activating mutations (3) 3
antibodies, monoclonal - adverse effects (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
article (3) 3
bevacizumab (3) 3
cell biology (3) 3
clinical trials as topic (3) 3
colorectal cancer (3) 3
disease progression (3) 3
disease-free survival (3) 3
double-blind method (3) 3
follow-up studies (3) 3
growth-factor-receptor (3) 3
hematology, oncology and palliative medicine (3) 3
medical colleges (3) 3
medicine & public health (3) 3
non-small-cell lung cancer (3) 3
oncology, experimental (3) 3
open-label (3) 3
platinum (3) 3
prognosis (3) 3
quinazolines - therapeutic use (3) 3
receptor protein-tyrosine kinases - genetics (3) 3
survival analysis (3) 3
treatment outcome (3) 3
tyrosine (3) 3
tyrosine kinase inhibitor (3) 3
tyrosine kinase inhibitors (3) 3
young adult (3) 3
2nd-line treatment (2) 2
adenocarcinoma - genetics (2) 2
adenocarcinoma - pathology (2) 2
adolescent (2) 2
anaplastic lymphoma kinase (2) 2
animals (2) 2
antibody (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 257 - 265
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9944, pp. 665 - 673
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 8, pp. 753 - 762
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 6, pp. 521 - 529
Journal Article
by Seidel, Danila and Zander, Thomas and Heukamp, Lukas C and Peifer, Martin and Bos, Marc and Fernandez-Cuesta, Lynnette and Leenders, Frauke and Lu, Xin and Ansen, Sascha and Gardizi, Masyar and Nguyen, Chau and Berg, Johannes and Russell, Prudence and Wainer, Zoe and Schildhaus, Hans-Ulrich and Rogers, Toni-Maree and Solomon, Benjamin and Pao, William and Carter, Scott L and Getz, Gad and Hayes, D. Neil and Wilkerson, Matthew D and Thunnissen, Erik and Travis, William D and Perner, Sven and Wright, Gavin and Brambilla, Elisabeth and Buettner, Reinhard and Wolf, Juergen and Thomas, Roman and Gabler, Franziska and Wilkening, Ines and Mueller, Christian and Dahmen, Ilona and Menon, Roopika and Koenig, Katharina and Albus, Kerstin and Merkelbach-Bruse, Sabine and Fassunke, Jana and Schmitz, Katja and Kuenstlinger, Helen and Kleine, Michaela and Binot, Elke and Querings, Silvia and Altmueller, Janine and Boessmann, Ingelore and Nuemberg, Peter and Schneider, Peter and Bogus, Magdalena and Soltermann, Alex and Moch, Holger and Brustugun, Odd Terje and Solberg, Steinar and Lund-Iversen, Marius and Helland, Aslaug and Muley, Thomas and Hoffmann, Hans and Schnabel, Philipp A and Chen, Yuan and Groen, Harry and Timens, Wim and Sietsma, Hannie and Clement, Joachim H and Weder, Walter and Saenger, Joerg and Stoelben, Erich and Ludwig, Corinna and Engel-Riedel, Walburga and Smit, Egbert and Heideman, Danille A. M and Snijders, Peter J. F and Nogova, Lucia and Sos, Martin L and Mattonet, Christian and Toepelt, Karin and Scheffler, Matthias and Goekkurt, Eray and Kappes, Rainer and Krueger, Stefan and Kambartel, Kato and Behringer, Dirk and Schulte, Wolfgang and Galetke, Wolfgang and Randerath, Winfried and Heldwein, Matthias and Schlesinger, Aneas and Serke, Monika and Hekmat, Khosro and Frank, Konrad F and Schnell, Roland and Reiser, Marcel and Huenerlituerkoglu, Ali-Nuri and Schmitz, Stephan and Meffert, Lisa and Ko, Yon-Dschun and Litt-Lampe, Markus and Gerigk, Ulrich and Fricke, Rainer and Besse, Benjamin and Brambilla, Christian and ... and CLCGP and NGM and Clinical Lung Cancer Genome Project (CLCGP) and Network Genomic Medicine (NGM) and The Clinical Lung Cancer Genome Project (CLCGP) and Network Genomic Medicine (NGM)
Science Translational Medicine, ISSN 1946-6234, 10/2013, Volume 5, Issue 209, pp. 209ra153 - 209ra153
We characterized genome alterations in 1255 clinically annotated lung tumors of all histological subgroups to identify genetically defined and clinically... 
MEDICINE, RESEARCH & EXPERIMENTAL | GEFITINIB | FUSION | GENE | NRF2 | ADENOCARCINOMA | OPEN-LABEL | SQUAMOUS-CELL CARCINOMAS | CANCER | ACTIVATING MUTATIONS | DRIVER MUTATIONS | CELL BIOLOGY | Lung Neoplasms - genetics | Lung Neoplasms - classification | Automation | Genomics | Humans | Lung Neoplasms - pathology | Lung Neoplasms - diagnosis | Genome, Human - genetics
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 24, pp. 2288 - 2301
The addition of atezolizumab (anti–PD-L1 antibody) to a platinum-based chemotherapy regimen improved progression-free survival among patients who had not... 
PHASE-III TRIAL | CELLS | MEDICINE, GENERAL & INTERNAL | MULTICENTER | THERAPY | BEVACIZUMAB | ANTIBODY | OPEN-LABEL | CANCER | DOCETAXEL | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Carcinoma, Non-Small-Cell Lung - secondary | Anaplastic Lymphoma Kinase | Neoplasm Metastasis - drug therapy | Immunotherapy | Female | Paclitaxel - administration & dosage | Bevacizumab - administration & dosage | Carcinoma, Non-Small-Cell Lung - genetics | Carboplatin - administration & dosage | Carcinoma, Non-Small-Cell Lung - mortality | Genes, erbB-1 | B7-H1 Antigen - antagonists & inhibitors | Receptor Protein-Tyrosine Kinases - genetics | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Lung cancer, Non-small cell | Drug therapy | Research | Epidermal growth factor receptors | Liver | Non-small cell lung carcinoma | Oncology | Lymphocytes T | Metastasis | Cancer therapies | Patients | Bevacizumab | Metastases | Immunosuppression | Chemotherapy | Motivation | Medical prognosis | PD-L1 protein | Paclitaxel | Carboplatin | Population | Death | Vascular endothelial growth factor | Genotypes | Apoptosis | Tumors
Journal Article
Nature communications, ISSN 2041-1723, 2014, Volume 5, Issue 1, p. 3518
Journal Article
Science Translational Medicine, ISSN 1946-6234, 12/2010, Volume 2, Issue 62, pp. 62ra93 - 62ra93
Journal Article